Literature DB >> 6444267

Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients.

V A Koivisto, P Felig.   

Abstract

In seven insulin-dependent diabetic subjects the disappearance rate of 125I-labelled short-acting insulin from injection sites in the abdominal wall was 86% greater than from the leg (P less than 0.005) and 30% greater than from the arm (P less than 0.05). Absorption from the arm was 40% greater than from the leg (P less than 0.05). The postprandial rise in plasma glucose concentration varied inversely with the rate of insulin absorption and was 30 to 50 mg/dL less after abdominal than after leg injection; the glycemic response after arm injection was intermediate between that after leg and abdominal injection. These results indicate that changing the insulin injection site from the leg to the abdomen or arm accelerates the absorption of insulin and diminishes the postprandial rise in plasma glucose. Varying insulin injection sites within the same anatomic region rather than between different regions may diminish daily variations in insulin absorption and in metabolic control in insulin-dependent diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6444267     DOI: 10.7326/0003-4819-92-1-59

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  36 in total

1.  Insulin pens. Is delivery sacrificed to improve patient compliance?

Authors:  D Gordon
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

Review 2.  Competitive sport and the insulin-dependent diabetic patient.

Authors:  P M Greenhalgh
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

3.  Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming.

Authors:  Eda Cengiz; Stuart A Weinzimer; Jennifer L Sherr; Eileen M Tichy; Lori Carria; Darryll Cappiello; Amy Steffen; William V Tamborlane
Journal:  Diabetes Technol Ther       Date:  2013-12-24       Impact factor: 6.118

Review 4.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

5.  The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins.

Authors:  A J Francis; I Hanning; K G Alberti
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

6.  Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels.

Authors:  H Süsstrunk; B Morell; W H Ziegler; E R Froesch
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

7.  Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to Humans.

Authors:  Wolfgang F Richter; Hans-Peter Grimm; Marie-Hélène Gouy; Susi Søgaard; Caroline Kreuzer; Uwe Wessels; Dragomir Draganov; Chris Muenzer; Tonio Hoche
Journal:  AAPS J       Date:  2020-04-03       Impact factor: 4.009

8.  Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies.

Authors:  E W Kraegen; D J Chisholm
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

9.  Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen.

Authors:  J E Henriksen; M S Djurhuus; A Vaag; P Thye-Rønn; D Knudsen; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

Review 10.  Diabetes, insulin and exercise.

Authors:  E A Richter; H Galbo
Journal:  Sports Med       Date:  1986 Jul-Aug       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.